Treatment Of Urogenital Prolapse Research Articles

SC152 - Efficacy and safety of an ultralight, six-point, polypropylene vaginal mesh in the treatment of urogenital prolapse: a retrospective study

SC152 - Efficacy and safety of an ultralight, six-point, polypropylene vaginal mesh in the treatment of urogenital prolapse: a retrospective study

P0376 - Efficacy and safety of an ultralight, six-point, polypropylene vaginal mesh in the treatment of urogenital prolapse

P0376 - Efficacy and safety of an ultralight, six-point, polypropylene vaginal mesh in the treatment of urogenital prolapse

Changes in Sexual Function Following Uphold Transvaginal mesh Surgery for the Treatment of Urogenital Prolapse

Uphold transvaginal mesh implantation is an option for treating pelvic organ prolapse (POP). This prospective cohort study aims to evaluate the effect of Uphold transvaginal mesh implantation on female sexual function. 205 women with symptomatic POP were recruited and evaluated pre-operatively and re- evaluated six months post-operatively in terms of anatomical restoration, quality of life influenced by urinary incontinence and female sexual function. 30 women eventually completed the assessments and been statistically evaluated. The main outcome focused on sexual function. In our study, we found that Uphold transvaginal mesh surgery could achieve effective anatomical restoration of POP and better sexual function regardless of concomitant sling surgery.

Outcome of repeat surgery for genital prolapse using prolift-mesh

IntroductionUrogenital prolapse can have a significant impact on quality of life. The life time risk of requiring surgery for urogenital prolapse is 11%. Prolift mesh has recently been introduced to reduce repeat operation rate and for long-term benefit.ObjectiveTo evaluate the outcome of the treatment of urogenital prolapse with synthetic mesh.MethodsA retrospective review of case notes of all women who underwent prolift mesh insertion for prolapse between July 2004 and June 2005, at Royal Alexandra Hospital Paisley UK. We looked at the presenting complaints, previous operation, intraoperative complications and complications at six weeks and six months follow-up.ResultsTwenty-two procedures were carried out in the twelve months period. Age of the patients ranged from 55 to 82 years (median 64 yrs). Eleven had anterior Prolift (50%), Seven had posterior Prolift 31.8% and four total Prolift 18%. There were no intraoperative complications. All the patients had previous surgery for prolapse. Eight patients had anterior repair, six patients had posterior repair, and three patients had abdominal hysterectomy. Vaginal hysterectomy was carried out with mesh insertion as a concomitant procedure in seven cases (31.25%). All patients were seen at six weeks and six months after the surgery. Complications rate included mesh erosion one patient and suture material protruding in the vagina one patient, one patient had failed prolift operation. All the twenty-one patients were cured giving 95.4% success rate.ConclusionThe use of prolene mesh in pelvic reconstructive surgery was associated with good outcome and minimal complications in this study.

Outcome of Repeat Surgery for Genital Prolapse using Prolift-Mesh

Introduction: Urogenital prolapse can have a significant impact on quality of life. The life time risk of requiring surgery for urogenital prolapse is 11%. Prolift mesh has recently been introduced to reduce repeat operation rate and for long-term benefit Objective: To evaluate the outcome of the treatment of urogenital prolapse with synthetic mesh. Methods: A retrospective review of case notes of all women who underwent prolift mesh insertion for prolapse between July 2004 and June 2005, at Royal Alexandra Hospital Paisley UK. We looked at the presenting complaints, previous operation, intraoperative complications and complications at six weeks and six months follow-up. Results: Twenty-two procedures were carried out in the twelve months period. Age of the patients ranged from 55 to 82 years (median 64yrs). Eleven had anterior Prolift (50%), Seven had posterior Prolift 31.8% and four total Prolift 18%. There were no intraoperative complications. Operation times range from 40-60minutes, while the blood loss was 400millilitres on average. All the patients had previous surgery for prolapse. Eight patients had anterior repair, six patients had posterior repair, and three patients had abdominal hysterectomy. Vaginal hysterectomy was carried out with mesh insertion as a concomitant procedure in seven cases (31.25%).All patients were seen at six weeks and six months after the surgery. Complications rate included mesh erosion one patient and suture material protruding in the vagina one patient, one patient had failed prolift-operation. All the twenty-one patients were cured giving 95.4% success rate. Conclusion: The use of prolene mesh in repeat pelvic reconstructive surgery was associated with good outcome and minimal complications in this study.

Measuring quality of life in urogenital prolapse

Urogenital prolapse is a common, distressing condition. Although significant morbidity and certainly mortality related to this condition is extremely rare, it has a significant impact on quality of life (QoL). QoL has been used as a surrogate measure of patient satisfaction and success following treatment of prolapse. Although highly subjective, QoL has been acknowledged to be as important as physical disease state and there are now several validated questionnaires to assess both symptoms and their impact on patients’ lives. As these questionnaires are relatively long and therefore difficult to use in clinical settings, alternatives such as patient-centered goal achievement and global indices (Patient Global Impression of Improvement), which are simple and easy to use, have gained popularity. Incorporation of QoL as an outcome measure may help to tailor patient care and ultimately improve patient satisfaction following treatment of urogenital prolapse.